Community opioid treatment perspectives on contingency management: Perceived feasibility, effectiveness, and transportability of social and financial incentives

Journal of Substance Abuse Treatment

Volumn 45, Issue 2, 2013, Pages 242-248

  Hartzler, Bryan ^a   Rabun, Carl ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Contingency management; Innovation adoption; Treatment community views

Indexed keywords

OPIATE AGONIST;

ADMINISTRATIVE PERSONNEL; ADULT; ARTICLE; CLINICAL EFFECTIVENESS; COMMUNITY CARE; CONTENT ANALYSIS; CONTINGENCY MANAGEMENT; DRUG DEPENDENCE TREATMENT; FEASIBILITY STUDY; FEMALE; FINANCIAL MANAGEMENT; HEALTH CARE COST; HUMAN; INTERVIEW; MALE; MANAGEMENT STYLE; MEDICAL STAFF; MODEL; PATIENT SATISFACTION; PERSONNEL MANAGEMENT; PHYSICIAN; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL ASPECT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY HEALTH SERVICES; DATA COLLECTION; FEASIBILITY STUDIES; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; OPIOID-RELATED DISORDERS; PATIENT SATISFACTION; QUALITY OF LIFE; REINFORCEMENT (PSYCHOLOGY); REWARD;

EID: 84879184132     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2013.01.014     Document Type: Article

References (42)

1. Benishek L.A., Kirby K.C., Dugosh K.L., Pavodano A. Beliefs about the empirical support of drug abuse treatment interventions: A survey of outpatient treatment providers. Drug and Alcohol Dependence 2010, 107:202-208.
2. Bride B.E., Abraham A.J., Roman P.M. Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers. Journal of Substance Abuse Treatment 2011, 40:87-94.
3. Calsyn D.A., DeMarco F.J., Saxon A.J., Sloan K.L., Gibbon K. Evaluation of a minimal services treatment track as an alternative to discharge for non-compliant patients in opioid substitution treatment. American Journal of Public Health 2003, 93:1086-1088.
4. Cameron J., Ritter A. Contingency management: Perspectives of Australian service providers. Drug and Alcohol Review 2007, 26:183-189.
5. Carroll K.M., Rounsaville B.J. A vision of the next generation of behavioral therapies research in the addictions. Addiction 2007, 102:850-862.
6. Creswell J.W., Klassen A.C., Plano-Clark V.L., Clegg-Smith K. Best practices for mixed methods research in the health sciences 2011, Bethesda, MD, Office of Behavioral and Social Sciences Research. H.I. Meissner (Ed.).
7. Ducharme L.J., Knudsen H.K., Abraham A.J., Roman P.M. Counselor attitudes toward the use of motivational incentives in addiction treatment. American Journal of Addiction 2010, 19:496-503.
8. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32:321-329.
9. Dutra L., Stathopoulou G., Basden S.L., Leyro T.M., Powers M.B., Otto M.W. A meta-analytic review of psychosocial interventions for substance use disorders. The American Journal of Psychiatry 2008, 165:179-187.
10. Griffith J.D., Rowan-Szal G.A., Roark R.R., Simpson D.D. Contingency management in outpatient methadone treatment: A meta-analysis. Drug and Alcohol Dependence 2000, 58:55-66.
11. Hartzler B., Cotton A., Calsyn D.A., Guerra R., Gignoux E. Dissolution of a VA harm reduction program for opiate agonist treatment (OAT): Longitudinal impact on treatment retention, substance use and service utilization. The International Journal on Drug Policy 2010, 21:82-85.
12. Hartzler B., Donovan D.M., Tillotson C., Mongoue-Tchokote S., Doyle S., McCarty D. A multi-level approach to predicting community addiction treatment attitudes about contingency management. Journal of Substance Abuse Treatment 2012, 42:213-221.
13. Hartzler B, Rabun C. (in press). Community treatment adoption of contingency management: A conceptual profile of U.S. clinics based on innovativeness of executive staff. International Journal of Drug Policy.
14. Herbeck D.M., Hser Y., Teruya C. Empirically supported substance abuse treatment approaches: A survey of treatment providers' perspectives and practices. Addictive Behaviors 2008, 33:699-712.
15. Higgins S.T., Budney A.J., Bickel W.K., Hughes J., Foerg F.E., Badger G.J. Incentives improve outcome in outpatient behavioral treatment of cocaine dependence. Archives of General Psychiatry 1994, 51:568-576.
16. Higgins S.T., Budney A.J., Bickel W.K., Hughes J.R., Roerg F., Badger G.J. Achieving cocaine abstinence with a behavioral approach. The American Journal of Psychiatry 1993, 150:763-769.
17. Higgins S.T., Silverman K., Heil S.H. Contingency management in substance abuse treatment 2008, Guilford, New York.
18. Higgins S.T., Stitzer M.L., Bigelow G.E., Liebson I.A. Contingent methadone delivery: Effects on illicit-opiate use. Drug and Alcohol Dependence 1986, 17:311-322.
19. Iguchi M.Y., Stitzer M.L., Bigelow G.E., Liebson I.A. Contingency managment in methadone maintenance: Effects of reinforcing and aversive consequences on illicit polydrug use. Drug and Alcohol Dependence 1988, 22:1-7.
20. Kirby K.C., Benishek L.A., Dugosh K.L., Kerwin M.E. Substance abuse treatment providers' beliefs and objections regarding contingency management: Implications for dissemination. Drug and Alcohol Dependence 2006, 85:19-27.
21. Knudsen H.K., Roman P.m. Modeling the use of innovations in private treatment organizations: The role of absorptive capacity. Journal of Substance Abuse Treatment 2004, 26:51-59.
22. Lussier J.P., Heil S.H., Mongeon J.A., Badger G.J., Higgins S.T. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction 2006, 101:192-203.
23. Magura S., Casriel C., Goldsmith D.S., Strug D.L., Lipton D.S. Contingency contracting with polydrug-abusing methadone patients. Addictive Behaviors 1988, 13:113-118.
24. McCarty D.J., Fuler B.E., Arfken C., Miller M., Nunes E.V., Edmundson E., et al. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: Characteristics, opinions, and beliefs. Psychiatric Services 2007, 58:181-190.
25. McGovern M.P., Fox T.S., Xie H., Drake R.E. A survey of clinical practices and readiness to adopt evidence-based practicies: Dissemination research in an addiction treatment system. Journal of Substance Abuse Treatment 2004, 26:305-312.
26. Milby J.B., Garrett C., English C., Fritschi O., Clarke C. Take-home methadone: Contingency effects on drug-seeking and productivity of narcotic addicts. Addictive Behaviors 1978, 3:215-220.
27. Peirce J.M., Petry N.M., Stitzer M.L., Blaine J., Kolodner K., et al. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network Study. Archives of General Psychiatry 2006, 63:201-208.
28. Petry N.M., Martin B., Cooney J.L., Kranzler H.R. Give them prizes, and they will come: Contingency management for treatment of alcohol dependence. Journal of Consulting and Clinical Psychology 2000, 68:250-257.
29. Petry N.M., Peirce J., Stitzer M.L., Blaine J., Roll J.M., Cohen A., et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A national drug abuse treatment Clinical Trials Network study. Archives of General Psychiatry 2005, 62:1148-1156.
30. Prendergast M., Podus D., Finney J.W., Greenwell L., Roll J.M. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction 2006, 101:1546-1560.
31. Ritter A., Cameron J. Australian clinician attitudes towards contingency management: Comparing down under with America. Drug and Alcohol Dependence 2007, 87:312-315.
32. Rogers E.M. Diffusion of innovations 2003, Vol 5. The Free Press, New York.
33. Roman P.M., Abraham A.J., Rothrauff T.C., Knudsen H.K. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2010, 38(Suppl 1):S44-S52.
34. Sandelowski M. Sample size in qualitative research. Research in Nursing and Health 1995, 18:179-183.
35. Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Research in Nursing and Health 2000, 23:246-255.
36. Schmitz J.M., Rhoades H.M., Elk R., Creson D., Hussein I., Grabowski J. Medication take-home doses and contingency management. Experimental and Clinical Psychopharmacology 1998, 6:162-168.
37. Sinclair J.M.A., Burton A., Ashcroft R., Priebe S. Clinician and service user perceptions of implementing contingency management: A focus group study. Drug and Alcohol Dependence 2011, 119:56-63.
38. Stitzer M.L., Bickel W.K., Bigelow G.E., Liebson I.A. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug and Alcohol Dependence 1986, 18:341-348.
39. Stitzer M.L., Bigelow G.E., Lawrence C., Cohen J., D'Lugoff B., Hawthorne J. Medication take-home as a reinforcer in a methadone maintenance program. Addictive Behaviors 1977, 2:9-14.
40. Stitzer M.L., Bigelow G.E., Liebson I.A. Reducing drug use among methadone maintenance clients: Contingent reinforcement for morphine-free urines. Addictive Behaviors 1980, 5:333-340.
41. Stitzer M.L., Iguchi M.Y., Felch L.J. Contingent take-home incentives: Effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology 1992, 60:927-934.
42. Stitzer M.L., Petry N.M. Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology 2006, 2:411-434.